Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,319,739
+$4,163,322 QoQ
Shares Held
491,918
+31.8% QoQ
Ownership
0.326%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#50
of 294 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Dec 31, 2025CallValue
$2,312,192
CallShares
204,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. BHVN ranks #65 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in BHVN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,319,739 | 491,918 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,156,417 | 373,099 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,378,250 | 387,799 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $2,312,192 | 204,800 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $3,074,048 | 204,800 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $1,215,810 | 81,000 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $34,472,742 | 922,965 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $74,969,191 | 1,500,284 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,156,235 | 177,362 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $49,746,024 | 909,600 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $106,296,667 | 2,483,567 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $26,673,124 | 1,025,495 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $28,005,488 | 1,170,798 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $37,192,532 | 2,722,733 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,091,956 | 1,231,409 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $2,339,594 | 379,903 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||